COVID-19 Update: click here

×
News Release

Torchmark Subsidiary United American Provides Addtl Medicare Prescription Drug Program Information

September 09, 2005

Torchmark Corporation (NYSE: TMK) subsidiary United American provided additional information today regarding its announcement September 7, 2005, that United American has received Medicare Part D Prescription Drug plans approval from the Centers for Medicare and Medicaid Service (CMS), as follows: CMS has not yet extended an approved Part D sponsor's contract to United American which will grant United American the right to market its Part D prescription drug plans. CMS is expected to grant contracts to approved sponsors later this month.

Torchmark Corporation is a holding company specializing in life and supplemental health insurance for "middle income" Americans marketed through multiple distribution channels including direct response, and exclusive and independent agencies. Torchmark has several nationally recognized insurance subsidiaries. Globe Life And Accident is a direct-response provider of life insurance known for its administrative efficiencies. American Income Life provides individual life insurance to labor union members. Liberty National Life, one of the oldest traditional life insurers in the Southeast, is the largest life insurer in its home state of Alabama. United American has been a provider of Medicare supplement health insurance since 1966.

This press release may contain forward-looking statements within the meaning of the federal securities laws. These prospective statements reflect management's current expectations, but are not guarantees of future performance. Accordingly, please refer to Torchmark's cautionary statement regarding forward-looking statements, and the business environment in which the Company operates, contained in the Company's Form 10-K for the period ended December 31, 2004, and subsequent Forms 10-Q, on file with the Securities and Exchange Commission, and on the Company's web site at http://www.torchmarkcorp.com/ on the Investor Relations page. Torchmark specifically disclaims any obligation to update or revise any forward-looking statement because of new information, future developments or otherwise.

SOURCE Torchmark Corporation

CONTACT: Joyce Lane, Vice President, Investor Relations of Torchmark Corporation, +1-972-569-3627, or fax, +1-972-569-3282, or jlane@torchmarkcorp.com

Web site: http://www.torchmarkcorp.com/